Analysis of -lactamase phenotypes and carriage of selected -lactamase genes among Escherichia coli strains obtained from Kenyan patients during an 18-year period

BMC Microbiology

Volumn 12, Issue , 2012, Pages

  Kiiru, John ^a,b,c   Kariuki, Samuel ^a   Goddeeris, Bruno M ^b,d   Butaye, Patrick ^c,d  

^a KENYA MEDICAL RESEARCH INSTITUTE   (Kenya)

^b UNIVERSITY OF LEUVEN   (Belgium)

^c VETERINARY AND AGROCHEMICAL RESEARCH CENTRE   (Belgium)

^d GHENT UNIVERSITY   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; AZTREONAM; BETA LACTAMASE; BETA LACTAMASE CTX M 1; BETA LACTAMASE CTX M 14; BETA LACTAMASE CTX M 15; BETA LACTAMASE CTX M 3; BETA LACTAMASE CTX M 8; BETA LACTAMASE CTX M 9; BETA LACTAMASE SHV; BETA LACTAMASE SHV 1; BETA LACTAMASE SHV 109; BETA LACTAMASE SHV 12; BETA LACTAMASE SHV 5; BETA LACTAMASE TEM 1; BETA LACTAMASE TEM 103; BETA LACTAMASE TEM 125; BETA LACTAMASE TEM 152; BETA LACTAMASE TEM 158; BETA LACTAMASE TEM 50; BETA LACTAMASE TEM 52; BETA LACTAMASE TEM 78; CARBAPENEM DERIVATIVE; CEFEPIME; CEFOTAXIME; CEFOXITIN; CEFTAZIDIME; CEPHAMYCIN DERIVATIVE; EXTENDED SPECTRUM BETA LACTAMASE; PIPERACILLIN PLUS TAZOBACTAM; UNCLASSIFIED DRUG; ANTIINFECTIVE AGENT; BETA LACTAM;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; ESCHERICHIA COLI; GENE IDENTIFICATION; HUMAN; KENYA; NONHUMAN; PHENOTYPE; DRUG EFFECT; ENZYMOLOGY; ESCHERICHIA COLI INFECTION; GENETICS; GENOTYPE; ISOLATION AND PURIFICATION; METABOLISM; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; PREVALENCE;

ESCHERICHIA COLI;

ANTI-BACTERIAL AGENTS; BETA-LACTAM RESISTANCE; BETA-LACTAMASES; BETA-LACTAMS; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; GENOTYPE; HUMANS; KENYA; MICROBIAL SENSITIVITY TESTS; PHENOTYPE; PREVALENCE;

EID: 84864252207     PISSN: None     EISSN: 14712180     Source Type: Journal    
DOI: 10.1186/1471-2180-12-155     Document Type: Article

References (58)

1. Bacteremia due to extended-spectrum beta-lactamase-producing Enterobacteriaceae other than Escherichia coli and Klebsiella. Huang SS, Lee MH, Leu HS, J Microbiol Immunol Infect 2006 39 496 502
2. A functional classification scheme for beta-lactamases and its correlation with molecular structure. Bush K, Jacoby GA, Medeiros AA, Antimicrob Agents Chemother 1995 39 1211 1233
3. New beta-lactamases in gram-negative bacteria: diversity and impact on the selection of antimicrobial therapy. Bush K, Clin Infect Dis 2001 32 1085 1089
4. The CTX-M beta-lactamase pandemic. Canton R, Coque TM, Curr Opin Microbiol 2006 9 466 475
5. IRT and CMT beta-lactamases and inhibitor resistance. Canton R, Morosini MI, de la Maza OM, de la Pedrosa EG, Clin Microbiol Infect 2008 14 Suppl 1 53 62
6. More extended-spectrum beta-lactamases. Jacoby GA, Medeiros AA, Antimicrob Agents Chemother 1991 35 1697 1704
7. False extended-spectrum {beta}-lactamase phenotype in clinical isolates of Escherichia coli associated with increased expression of OXA-1 or TEM-1 penicillinases and loss of porins. Beceiro A, Maharjan S, Gaulton T, Doumith M, Soares NC, Dhanji H, Warner M, Doyle M, Hickey M, Downie G, Bou G, Livermore DM, Woodford N, J Antimicrob Chemother 2011 66 2006 2010
8. Variation in selected regions of blaTEM genes and promoters in Haemophilus influenzae. Tristram SG, Hawes R, Souprounov J, J Antimicrob Chemother 2005 56 481 484
9. Outer membrane protein alterations and blaTEM-1 variants: their role in beta-lactam resistance in Klebsiella pneumoniae. Nelson EC, Segal H, Elisha BG, J Antimicrob Chemother 2003 52 899 903
10. Promoters P3, Pa/Pb, P4, and P5 upstream from bla(TEM) genes and their relationship to beta-lactam resistance. Lartigue MF, Leflon-Guibout V, Poirel L, Nordmann P, Nicolas-Chanoine MH, Antimicrob Agents Chemother 2002 46 4035 4037
11. Extended-spectrum and inhibitor-resistant TEM-type beta-lactamases: mutations, specificity, and three-dimensional structure. Knox JR, Antimicrob Agents Chemother 1995 39 2593 2601
12. Transferable resistance to third-generation cephalosporins in clinical isolates of Klebsiella pneumoniae: identification of CTX-1, a novel beta-lactamase. Sirot D, Sirot J, Labia R, Morand A, Courvalin P, Darfeuille-Michaud A, Perroux R, Cluzel R, J Antimicrob Chemother 1987 20 323 334
13. Molecular characterization of nine different types of mutants among 107 inhibitor-resistant TEM beta-lactamases from clinical isolates of Escherichia coli. Henquell C, Chanal C, Sirot D, Labia R, Sirot J, Antimicrob Agents Chemother 1995 39 427 430
14. Analysis of the effects of 42 and 32 ampC promoter mutations in clinical isolates of Escherichia coli hyperproducing ampC. Caroff N, Espaze E, Gautreau D, Richet H, Reynaud A, J Antimicrob Chemother 2000 45 783 788
15. Klebsiella pneumoniae carbapenemase (KPC)-producing Klebsiella pneumoniae: a review of epidemiological and clinical aspects. da Silva RM, Traebert J, Galato D, Expert Opin Biol Ther 2012 663 671
16. Rapid evolution and spread of carbapenemases among Enterobacteriaceae in Europe. Canton R, Akova M, Carmeli Y, Giske CG, Glupczynski Y, Gniadkowski M, Livermore DM, Miriagou V, Naas T, Rossolini GM, Samuelsen O, Seifert H, Woodford N, Nordmann P, Clin Microbiol Infect 2012 18 413 431
17. Carbapenem resistance in Enterobacteriaceae: here is the storm! Nordmann P, Dortet L, Poirel L, Trends Mol Med 2012 18 5 263 272
18. Emerging carbapenemases in Gram-negative aerobes. Nordmann P, Poirel L, Clin Microbiol Infect 2002 8 321 331
19. Occurrence of extended-spectrum and AmpC beta-lactamases in bloodstream isolates of Klebsiella pneumoniae: isolates harbor plasmid-mediated FOX-5 and ACT-1 AmpC beta-lactamases. Coudron PE, Hanson ND, Climo MW, J Clin Microbiol 2003 41 2 772 777
20. CTX-M-15-producing Escherichia coli clone B2-O25b-ST131 and Klebsiella spp. isolates in municipal wastewater treatment plant effluents. Dolejska M, Frolkova P, Florek M, Jamborova I, Purgertova M, Kutilova I, Cizek A, Guenther S, Literak I, J Antimicrob Chemother 2011 66 2784 2790
21. DNA sequence analysis of the genetic environment of various blaCTX-M genes. Eckert C, Gautier V, Arlet G, J Antimicrob Chemother 2006 57 1 14 23
22. Large-scale population structure of human commensal Escherichia coli isolates. Escobar-Paramo P, Grenet K, Le MA, Rode L, Salgado E, Amorin C, Gouriou S, Picard B, Rahimy MC, Andremont A, Denamur E, Ruimy R, Appl Environ Microbiol 2004 70 5698 5700
23. Characterization of a novel extended-spectrum beta-lactamase phenotype from OXA-1 expression in Salmonella Typhimurium strains from Africa and Ireland. Boyle F, Healy G, Hale J, Kariuki S, Cormican M, Morris D, Diagn Microbiol Infect Dis 2011 70 549 553
24. Escherichia coli strains from Kenyan patients carrying conjugatively transferable broad-spectrum beta-lactamase, qnr, aac(6')-Ib-cr and 16S rRNA methyltransferase genes. Kiiru J, Kariuki S, Goddeeris BM, Revathi G, Maina TW, Ndegwa DW, Muyodi J, Butaye P, J Antimicrob Chemother 2011 66 1639 1642
25. Detection of NDM-1-producing Klebsiella pneumoniae in Kenya. Poirel L, Revathi G, Bernabeu S, Nordmann P, Antimicrob Agents Chemother 2011 55 934 936
26. Metallo-beta-lactamase-producing Pseudomonas aeruginosa isolated from a large tertiary centre in Kenya. Pitout JD, Revathi G, Chow BL, Kabera B, Kariuki S, Nordmann P, Poirel L, Clin Microbiol Infect 2008 14 755 759
27. Molecular characterization of a novel plasmid-encoded cefotaximase (CTX-M-12) found in clinical Klebsiella pneumoniae isolates from Kenya. Kariuki S, Corkill JE, Revathi G, Musoke R, Hart CA, Antimicrob Agents Chemother 2001 45 2141 2143
28. Plasmid diversity of multi-drug-resistant Escherichia coli isolated from children with diarrhoea in a poultry-farming area in Kenya. Kariuki S, Gilks CF, Kimari J, Muyodi J, Waiyaki P, Hart CA, Ann Trop Med Parasitol 1997 91 87 94
29. Prevalence of clinical isolates of Escherichia coli producing inhibitor-resistant beta-lactamases at a University Hospital in Barcelona, Spain, over a 3-year period. Miro E, Navarro F, Mirelis B, Sabate M, Rivera A, Coll P, Prats G, Antimicrob Agents Chemother 2002 46 3991 3994
30. Mechanisms of reduced susceptibility to amoxycillin-clavulanic acid in Escherichia coli strains from the health region of Tortosa (Catalonia, Spain). Perez-Moreno MO, Perez-Moreno M, Carulla M, Rubio C, Jardi AM, Zaragoza J, Clin Microbiol Infect 2004 10 234 241
31. Spread of extended-spectrum beta-lactamase CTX-M-producing escherichia coli clinical isolates in community and nosocomial environments in Portugal. Mendonca N, Leitao J, Manageiro V, Ferreira E, Canica M, Antimicrob Agents Chemother 2007 51 1946 1955
32. Faecal carriage of extended-spectrum beta-lactamase-producing Escherichia coli: prevalence, risk factors and molecular epidemiology. Rodriguez-Bano J, Lopez-Cerero L, Navarro MD, de Diaz AP, Pascual A, J Antimicrob Chemother 2008 62 1142 1149
33. Animal reservoirs for extended spectrum beta-lactamase producers. Carattoli A, Clin Microbiol Infect 2008 14 Suppl 1 117 123
34. Trends in fluoroquinolone (ciprofloxacin) resistance in enterobacteriaceae from bacteremias, England and Wales, 1990-1999. Livermore DM, James D, Reacher M, Graham C, Nichols T, Stephens P, Johnson AP, George RC, Emerg Infect Dis 2002 8 473 478
35. Surveillance of community-based reservoirs reveals the presence of CTX-M, imported AmpC, and OXA-30 beta-lactamases in urine isolates of Klebsiella pneumoniae and Escherichia coli in a U.S. community. Hanson ND, Moland ES, Hong SG, Propst K, Novak DJ, Cavalieri SJ, Antimicrob Agents Chemother 2008 52 3814 3816
36. Extended-spectrum-beta-lactamase-producing Enterobacteriaceae in Yaounde, Cameroon. Gangoue-Pieboji J, Bedenic B, Koulla-Shiro S, Randegger C, Adiogo D, Ngassam P, Ndumbe P, Hachler H, J Clin Microbiol 2005 43 3273 3277
37. CTX-M: changing the face of ESBLs in Europe. Livermore DM, Canton R, Gniadkowski M, Nordmann P, Rossolini GM, Arlet G, Ayala J, Coque TM, Kern-Zdanowicz I, Luzzaro F, Poirel L, Woodford N, J Antimicrob Chemother 2007 59 165 174
38. beta-Lactamases responsible for resistance to expanded-spectrum cephalosporins in Klebsiella pneumoniae, Escherichia coli, and Proteus mirabilis isolates recovered in South Africa. Pitout JD, Thomson KS, Hanson ND, Ehrhardt AF, Moland ES, Sanders CC, Antimicrob Agents Chemother 1998 42 1350 1354
39. Community-acquired extended-spectrum beta-lactamase producers, United States. Doi Y, Adams J, O'Keefe A, Quereshi Z, Ewan L, Paterson DL, Emerg Infect Dis 2007 13 1121 1123
40. Dissemination of an extended-spectrum-beta-lactamase blaTEM-52 gene-carrying IncI1 plasmid in various Salmonella enterica serovars isolated from poultry and humans in Belgium and France between 2001 and 2005. Cloeckaert A, Praud K, Doublet B, Bertini A, Carattoli A, Butaye P, Imberechts H, Bertrand S, Collard JM, Arlet G, Weill FX, Nakaya R, Antimicrob Agents Chemother 2007 51 1872 1875
41. Intercontinental emergence of Escherichia coli clone O25:H4-ST131 producing CTX-M-15. Nicolas-Chanoine MH, Blanco J, Leflon-Guibout V, Demarty R, Alonso MP, Canica MM, Park YJ, Lavigne JP, Pitout J, Johnson JR, J Antimicrob Chemother 2008 61 273 281
42. Novel complex class 1 integron bearing an ISCR1 element in an Escherichia coli isolate carrying the blaCTX-M-14 gene. Bae IK, Lee YN, Lee WG, Lee SH, Jeong SH, Antimicrob Agents Chemother 2007 51 3017 3019
43. Replicon typing of plasmids carrying CTX-M or CMY beta-lactamases circulating among Salmonella and Escherichia coli isolates. Hopkins KL, Liebana E, Villa L, Batchelor M, Threlfall EJ, Carattoli A, Antimicrob Agents Chemother 2006 50 3203 3206
44. Cowan ST, Cowan and Steel's manual for identification of medical bacteria Cambridge University Press, Cambridge 2 1985
45. Clinical and Laboratory Standards Institute (CLSI), Performance standardsfor antimicrobial susceptibility testing; 15th informational supplement (M100-S15) Clinical Laboratory Standards Institute, Wayne PA, USA: CLSI 2007
46. Molecular characterization of plasmids encoding CTX-M-15 beta-lactamases from Escherichia coli strains in the United Kingdom. Karisik E, Ellington MJ, Pike R, Warren RE, Livermore DM, Woodford N, J Antimicrob Chemother 2006 58 665 668
47. Escherichia coli from community-acquired urinary tract infections resistant to fluoroquinolones and extended-spectrum beta-lactams. Kariuki S, Revathi G, Corkill J, Kiiru J, Mwituria J, Mirza N, Hart CA, J Infect Dev Ctries 2007 1 257 262
48. Substitution of alanine for aspartate at position 179 in the SHV-6 extended-spectrum beta-lactamase. Arlet G, Rouveau M, Philippon A, FEMS Microbiol Lett 1997 152 163 167
49. Molecular characterisation by PCR-restriction fragment length polymorphism of TEM beta-lactamases. Arlet G, Brami G, Decre D, Flippo A, Gaillot O, Lagrange PH, Philippon A, FEMS Microbiol Lett 1995 134 203 208
50. Diversity of genetic environment of bla(CTX-M) genes. Lartigue MF, Poirel L, Nordmann P, FEMS Microbiol Lett 2004 234 201 207
51. Animal and human multidrug-resistant, cephalosporin-resistant salmonella isolates expressing a plasmid-mediated CMY-2 AmpC beta-lactamase. Winokur PL, Brueggemann A, DeSalvo DL, Hoffmann L, Apley MD, Uhlenhopp EK, Pfaller MA, Doern GV, Antimicrob Agents Chemother 2000 44 2777 2783
52. Phenotypic and molecular detection of CTX-M-beta-lactamases produced by Escherichia coli and Klebsiella spp. Pitout JD, Hossain A, Hanson ND, J Clin Microbiol 2004 42 5715 5721
53. beta-Lactamases among extended-spectrum beta-lactamase (ESBL)-resistant Salmonella from poultry, poultry products and human patients in The Netherlands. Hasman H, Mevius D, Veldman K, Olesen I, Aarestrup FM, J Antimicrob Chemother 2005 56 115 121
54. Prevalence of beta-lactamases among ampicillin-resistant Escherichia coli and Salmonella isolated from food animals in Denmark. Olesen I, Hasman H, Aarestrup FM, Microb Drug Resist 2004 10 334 340
55. Extended-spectrum beta-lactamase-producing strain of Acinetobacter baumannii isolated from a patient in France. Poirel L, Karim A, Mercat A, Le Thomas I, Vahaboglu H, Richard C, Nordmann P, J Antimicrob Chemother 1999 43 157 158
56. Nosocomial outbreak by Proteus mirabilis producing extended-spectrum beta-lactamase VEB-1 in a Korean university hospital. Kim JY, Park YJ, Kim SI, Kang MW, Lee SO, Lee KY, J Antimicrob Chemother 2004 54 1144 1147
57. Emergence of DHA-1-producing Klebsiella spp. in the Parisian region: genetic organization of the ampC and ampR genes originating from Morganella morganii. Verdet C, Benzerara Y, Gautier V, Adam O, Ould-Hocine Z, Arlet G, Antimicrob Agents Chemother 2006 50 607 617
58. CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Thompson JD, Higgins DG, Gibson TJ, Nucleic Acids Res 1994 22 4673 4680